Seeking Alpha

Infinity Pharmaceuticals, Inc. (INFI)

From other sites
Visit Seeking Alpha's
INFI vs. ETF Alternatives
Company Description
Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its primary product candidate is duvelisib, also known as IPI-145, an oral inhibitor.
Sector: Services
Country: United States